| FKAIX | VISGX | FKAIX / VISGX | |
| Total Expense Ratio | 0.90 | 0.19 | 474% |
| Annual Report Gross Expense Ratio | 1.02 | 0.19 | 537% |
| Fund Existence | 11 years | 28 years | - |
| Gain YTD | 16.176 | 18.831 | 86% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.93B | 43.9B | 7% |
| Annual Yield % from dividends | 0.00 | 0.33 | - |
| Returns for 1 year | 1.56 | 26.36 | 6% |
| Returns for 3 years | 19.75 | 62.59 | 32% |
| Returns for 5 years | -19.98 | 29.67 | -67% |
| Returns for 10 years | 115.52 | 175.15 | 66% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EMCS | 45.77 | 0.57 | +1.27% |
| Xtrackers MSCI EMs Select ETF | |||
| VXUS | 87.71 | 0.68 | +0.78% |
| Vanguard Total International Stock ETF | |||
| SELV | 35.09 | 0.27 | +0.76% |
| SEI QiM U.S. Lrg Cap Low Volatil Act ETF | |||
| FDTS | 69.86 | 0.11 | +0.16% |
| First Trust DevMkts exUS SC AlphaDEX®ETF | |||
| LABD | 6.29 | -0.27 | -4.12% |
| Direxion Daily S&P Biotech Bear 3X ETF | |||